MEDLAB 2017

Visit us at our booth and meet Cerus experts and representatives from our distributor network.

Highlight: Dr. Andreas Buser, Director; Blood Transfusion Services, Swiss Red Cross, Basel, Switzerland, will speak about "The rational for pathogen inactivation implementation".

Through the INTERCEPT Blood System, the foremost pathogen inactivation technology for platelets and plasma in the world, Cerus is leading the way to higher standards for blood safety and better patient outcomes.
The INTERCEPT Blood System for Red Blood Cells is in clinical development, not commercially available.

Visit the MEDLAB website